Trial Profile
Direct to Patient Survey to Examine Treatment Satisfaction and Experience With Dapagliflozin Compared to Sulfonylureas
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary) ; Dapagliflozin/metformin (Primary) ; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 14 Nov 2018 Status changed from recruiting to completed.
- 16 Jul 2018 Planned End Date changed from 31 Jul 2018 to 29 Oct 2018.
- 16 Jul 2018 Planned primary completion date changed from 31 Jul 2018 to 29 Oct 2018.